NOVN.CH

117.02

+0.26%↑

NOVN.CH

117.02

+0.26%↑

NOVN.CH

117.02

+0.26%↑

NOVN.CH

117.02

+0.26%↑

NOVN.CH

117.02

+0.26%↑

Home・Aandelen Lijst・Roche Holding AG
Search

Roche Holding AG

Gesloten

SectorGezondheidszorg

330.4 0.85

Prijsupdate 15 mei 2026, 15:19 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

330

Max

334.6

Belangrijke statistieken

By Trading Economics

Inkomsten

1.8B

5.5B

Verkoop

15B

31B

K/W

Sectorgemiddelde

20.312

51.415

Dividendrendement

3

Winstmarge

17.892

Werknemers

103,249

EBITDA

5.1B

12B

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

3.00%

2.34%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-30B

259B

Vorige openingsprijs

329.55

Vorige sluitingsprijs

330.4

Nieuwssentiment

By Acuity

45%

55%

139 / 345 Rangschikking in Healthcare

Roche Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 mei 2026, 06:06 UTC

Acquisities, Fusies, Overnames

Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools

DJ

Lezen

23 apr 2026, 07:46 UTC

Winsten

Roche Backs Full-Year View as Quarterly Sales Rise -- Update

DJ

Lezen

23 apr 2026, 05:40 UTC

Winsten

Roche Backs Full-Year View as Quarterly Sales Rise

DJ

Lezen

9 mrt 2026, 16:43 UTC

Belangrijke Marktbewegers

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study -- Update

DJ

Lezen

9 mrt 2026, 15:44 UTC

Belangrijke Marktbewegers

Correction to Roche Shares Article

DJ

Lezen

9 mrt 2026, 09:51 UTC

Belangrijke Marktbewegers

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study

DJ

Lezen

6 mrt 2026, 09:24 UTC

Belangrijke Marktbewegers

Zealand Pharma Shares Plunge After Obesity Drug Candidate Disappoints in Trial

DJ

Lezen

13 mei 2026, 10:20 UTC

Marktinformatie
Winsten

Roche Strikes Upbeat Tone on Long-Term Outlook -- Market Talk

DJ

Lezen

7 mei 2026, 05:53 UTC

Acquisities, Fusies, Overnames

Correct: Roche to Buy PathAI for up to $1.05B

DJ

Lezen

7 mei 2026, 05:07 UTC

Acquisities, Fusies, Overnames

Roche: Acquisition Expected to Complete in 2H

DJ

Lezen

7 mei 2026, 05:06 UTC

Acquisities, Fusies, Overnames

Roche: Closing of Deal Subject to Customary Closing Conditions

DJ

Lezen

7 mei 2026, 05:06 UTC

Acquisities, Fusies, Overnames

Roche to Pay $750M Upfront, Milestone Payments of Up to $300M

DJ

Lezen

7 mei 2026, 05:06 UTC

Acquisities, Fusies, Overnames

Roche to Buy PathAI for up to $1.5B

DJ

Lezen

7 mei 2026, 05:05 UTC

Acquisities, Fusies, Overnames

Roche to Buy PathAI

DJ

Lezen

6 mei 2026, 22:50 UTC

Winsten

Sarepta Stock Sinks on Earnings Beat. Elevidys Demand Faces a Reality Check. -- Barrons.com

DJ

Lezen

27 apr 2026, 09:54 UTC

Marktinformatie

Roche's Vabysmo U.S. Recovery Will Be Key -- Market Talk

DJ

Lezen

23 apr 2026, 08:10 UTC

Marktinformatie
Winsten

Roche Reports In Line Sales Figures -- Market Talk

DJ

Lezen

23 apr 2026, 05:04 UTC

Winsten

Roche Backs 2026 View

DJ

Lezen

23 apr 2026, 05:04 UTC

Winsten

Roche Diagnostics Division 1Q Sales Up at 3% Constant Currency

DJ

Lezen

23 apr 2026, 05:03 UTC

Winsten

Roche Pharmaceutical Division 1Q Sales Up 7% at Constant Currency

DJ

Lezen

23 apr 2026, 05:02 UTC

Winsten

Roche 1Q Group Sales Up 6% at Constant Currency

DJ

Lezen

23 apr 2026, 05:02 UTC

Winsten

Analysts Saw Roche 1Q Sales at CHF14.73B

DJ

Lezen

23 apr 2026, 05:01 UTC

Winsten

Roche 1Q Sales CHF14.72B

DJ

Lezen

10 apr 2026, 11:28 UTC

Marktinformatie

Roche's Longer-Term Outlook to Take Spotlight at Diagnostics Event -- Market Talk

DJ

Lezen

10 apr 2026, 11:17 UTC

Marktinformatie

Roche to Face Significant Currency Headwinds -- Market Talk

DJ

Lezen

11 mrt 2026, 10:57 UTC

Marktinformatie

Roche Sees Mixed Fortunes in Immunology, Oncology -- Market Talk

DJ

Lezen

9 mrt 2026, 09:43 UTC

Populaire aandelen

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

DJ

Lezen

6 mrt 2026, 07:22 UTC

Marktinformatie

Roche, Zealand Pharma Obesity Drug Falls Short of Expectations -- Market Talk

DJ

Lezen

3 mrt 2026, 07:22 UTC

Marktinformatie

Roche's Multiple Sclerosis Drug Safety Remains in Focus After Latest Trial -- Market Talk

DJ

Lezen

2 mrt 2026, 14:21 UTC

Marktinformatie

Roche's Multiple Sclerosis Drug Might Not Clear FDA Bar -- Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

Roche Holding AG Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Roche Holding AG - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

139 / 345 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Andere aandelen uit de sector

NOVN.CH

Novartis AG

117.02

↑ +0.26%
help-icon Live chat